GTS Securities’s Corgi Genomics & Precision Medicine ETF GNMX Stock Holding History
Bought
Maintained
Sold
GTS Securities's GNMX Position: Q2 2026 in Review
GTS Securities opened a new position in Corgi Genomics & Precision Medicine ETF (GNMX) in Q2 2026: 12,435 shares worth $387K. The stake represents 0.01% of the portfolio and ranks #848 among its holdings.
1 fund tracked by Wall St. Rank holds GNMX as of Q2 2026.
- GTS Securities held 12,435 shares of Corgi Genomics & Precision Medicine ETF worth $387K as of Q2 2026.
- Corgi Genomics & Precision Medicine ETF was a new GTS Securities position in Q2 2026.
- Corgi Genomics & Precision Medicine ETF made up 0.01% of GTS Securities's portfolio in Q2 2026, its #848 holding.
- 1 fund tracked by Wall St. Rank held Corgi Genomics & Precision Medicine ETF as of Q2 2026.
Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.